Dr. Emerson C. Perin, Medical Director at The Texas Heart Institute, has been highlighted as the lead investigator in the...
The Texas Heart Institute and the European Society for Cardiology Working Group for Cardiovascular Regenerative and Reparative Medicine hosted their 3rd Symposium...
The Texas Heart Institute Biorepository and Biospecimen Profiling Core Laboratory has been reaccredited by the College of American Pathologists (CAP)...
New Cell Therapy Offers Potential Treatment Option for Patients With Chronic Heart Failure Houston, TX – February 27, 2023 –...
Investigators at The Texas Heart Institute (THI) have gained new insights into patient-related factors that may affect clinical outcomes after...
Advances in biomedical research are often hailed for their potential in treating a variety of human conditions, but many of...
HOUSTON, TX (DECEMBER 7, 2021) – The Texas Heart Institute is pleased to announce that Dr. Darren G. Woodside, Senior...
HOUSTON, TX (December 8, 2021) – The Texas Heart Institute Biorepository is proud to announce its third reaccreditation by the...
THI Medical Director Emerson C. Perin, MD, PhD, outlines Phase 3 Clinical Trial Results Demonstrate Promising Stem Cell Treatment Options...
HOUSTON, TX – June 2021 – Drs. Kirstin Matthews (Baker Institute) and Emerson Perin (THI) spearhead a joint research and...
Autologous bone marrow‐derived mesenchymal stromal cells (MSCs) and ckit positive cardiac cells (CPCs) show promise in Phase II study HOUSTON,...
In response to the evolving Covid-19 pandemic, the Texas Heart Institute (THI) is dedicating its education series, Innovative Technologies & Techniques, to...
Visit U.S. News & World Report
